Sun Pharmaceutical Industries Share Price Today - Live Blog for July 31, 2025

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.06% increase and currently trading at ₹1,700.95 per share. Investors are taking notice of this upward momentum.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.16%, signalling a challenging period. Currently trading at ₹1,704.95, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Sun Pharmaceutical Industries Ltd experienced a -0.35% dip in its share price and is currently trading at ₹1,713.50. The stock has a PE ratio of 38.0900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd experienced a -0.35% downturn in its share price, and it's currently trading at ₹1,713.50. This situation is generating interest among value investors who are evaluating the stock's potential.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.77%, with the current market value at ₹1,719.60 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.31%, reaching the current market price of ₹1,735.80. This development underscores the stock's growing popularity.

Sun Pharmaceutical Industries Ltd share price surged by 0.31%. With its current market price standing at ₹1,735.80 per share, this stock is garnering increased attention from the investment community.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.10% surge in its share price and is presently trading at ₹1,730.50, captivating the attention of market participants.

With a remarkable 0.14% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,728.00. Notably, this stock has a Price-to-Earnings (PE) ratio of 38.0900, while the industry's PE ratio is 36.0010.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.12%, with the current market value at ₹1,725.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.09% drop, and it's now trading at ₹1,727.10 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Sun Pharmaceutical Industries Ltd share price has declined by -0.29%, and it's currently trading at ₹1,730.25. The stock maintains a PE of 38.0900, while the industry PE is 36.0010, prompting discussions about its valuation.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.23%, and it is currently trading at ₹1,735.45. Additionally, the stock maintains a PE ratio of 38.0900, while the industry PE is 36.0010.

The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.13% increase. Presently, it is actively trading at ₹1,732.05.

With a -0.19% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,729.80. The stock is currently trading at a PE of 38.0900, while the industry PE is 36.0010, prompting investors to assess its value proposition.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.19%, signalling a challenging period. Currently trading at ₹1,729.80, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.31%, a situation worth noting. At present, the stock is trading at ₹1,732.80. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 38.0900, while the industry PE ratio is 36.0010.

With a -0.02% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,736.00. Investors should examine the factors driving this decline. The stock's PE ratio is 38.0900, whereas the industry PE ratio stands at 36.0010.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.12%. At this moment, it's actively trading at ₹1,732.00, presenting an enticing opportunity for those in the market.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.30% increase and currently trading at ₹1,731.15 per share. Investors are taking notice of this upward momentum.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.34% surge in its share price and is presently trading at ₹1,725.85. The increased investor interest is driving this surge.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.13%, reaching the current market price of ₹1,719.80. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.05% in its share price, and it currently trades at ₹1,716.25 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd witnessed a -0.15% decrease in its share price, and it is currently trading at ₹1,718.50. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 38.0900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

With a -0.52% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,721.00. The stock is currently trading at a PE of 38.0900, while the industry PE is 36.0010, prompting investors to assess its value proposition.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.24%, with its current market value per share resting at ₹1,727.00. This development highlights the stock's appeal to investors.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.63%, and as of now, it's trading at ₹1,722.05 per share. This upward trajectory is attracting keen interest from investors.